State of Wisconsin Investment Board’s Lifecore Biomedical LFCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$135K Sell
36,261
-1,564
-4% -$10.8K ﹤0.01% 2394
2025
Q4
$309K Buy
37,825
+21,946
+138% +$162K ﹤0.01% 2152
2025
Q3
$117K Buy
+15,879
New +$120K ﹤0.01% 2314
2023
Q3
Sell
-53,800
Closed -$520K 2566
2023
Q2
$520K Buy
53,800
+36,100
+204% +$220K ﹤0.01% 1810
2023
Q1
$66.8K Buy
+17,700
New +$98.7K ﹤0.01% 2433

Other funds holding LFCR

State of Wisconsin Investment Board's LFCR Position: Q1 2026 in Review

State of Wisconsin Investment Board reduced its Lifecore Biomedical (LFCR) stake by 4.1% in Q1 2026, selling an estimated $10.8K and leaving 36,261 shares worth $135K. The position accounts for ﹤0.01% of the portfolio, ranked #2394.

State of Wisconsin Investment Board first reported a position in LFCR in Q1 2023 and has held it in 5 quarters since. The position peaked at $520K in Q2 2023. 105 funds tracked by Wall St. Rank hold LFCR as of Q1 2026.

  • State of Wisconsin Investment Board held 36,261 shares of Lifecore Biomedical worth $135K as of Q1 2026.
  • State of Wisconsin Investment Board sold 1,564 Lifecore Biomedical shares in Q1 2026, an estimated $10.8K.
  • Lifecore Biomedical made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #2394 holding.
  • State of Wisconsin Investment Board first reported a position in Lifecore Biomedical in Q1 2023 and has held it in 5 quarters since.
  • State of Wisconsin Investment Board's Lifecore Biomedical position peaked at $520K in Q2 2023.
  • 105 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.